Share tips
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
How to pick shares
Anyone can buy shares. But how do you decide which shares to buy? Discover three easy ways to pick shares now. Download your free guide to picking shares
Press tips from ShareCast
-
Sunday newspaper round-up: BP, Defence, Tesla
Sun 09 March 2025 12:24
(Sharecast News) - Hedge fund Elliott wants BP to let go its petrol stations and move aggressively to improve its performance. BP management is preparing for a push in that regard by the activist investor. Elliott has already expressed its dissatisfaction... -
Sunday share tips: Londonmetric
Sun 14 July 2024 12:01
(Sharecast News) - The Financial Mail on Sunday's Midas column tipped shares of LondonMetric to its readers, highlighting its long record of dividend payouts, focus on the fast-growing bits of the economy and "rude" financial health.... -
Sunday share tips: UK shares, Kitwave
Sun 07 July 2024 10:15
(Sharecast News) - Investment specialists are positive on the outlook for shares in the UK in the wake of Labour's victory, the Financial Mail on Sunday's Midas column said....
Broker tips from ShareCast
-
RBC Capital downgrades Schroders, lifts PT on Nuveen takeover
Mon 16 February 2026 09:42
(Sharecast News) - RBC Capital Markets downgraded Schroders on Monday to 'sector perform' from 'outperform' but lifted the price target to 610p from 440p to reflect the total consideration of its takeover bid from Nuveen. -
Broker tips: AstraZeneca, Morgan Sindall
Fri 13 February 2026 14:11
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery. -
Shore Capital lowers AstraZeneca to 'hold'
Fri 13 February 2026 13:59
(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.
Buy shares online
Never pay more than £11.95 per deal for online deals
Open a low-cost dealing account in under 5 minutes